ODI Pharma AB (6OD) Stock Statistics & Valuation Metrics

ODI Pharma AB has a market cap or net worth of €3.78M. The enterprise value is ―.

ODI Pharma AB has 18,330,420 shares outstanding. The number of shares has decreased by -2.65% in one year.

ODI Pharma AB’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of ODI Pharma AB is ―. ODI Pharma AB’s PEG ratio is ―.

In the last 12 months, ODI Pharma AB had revenue of ― and earned -7.24M in profits. Earnings per share was ―.

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.

ODI Pharma AB pays an annual dividend of ―, resulting in a dividend yield of ―

ODI Pharma AB upcoming earnings date is Aug 27, 2026, TBA (Confirmed).

ODI Pharma AB as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, ODI Pharma AB has paid ― in taxes.

ODI Pharma AB EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

ODI Pharma AB has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for ODI Pharma AB is ―, which is 11.43% higher than the current price. The consensus rating is ―